Kyntra Bio (KYNB)

• Market cap: $28.2M
• 1 day: -0.71%
• 5 days: 3.26%
• 1 month: -6.44%
• 3 months: -30.58%
• 6 months: -41.13%
• Year to date: -23.91%
• 1 year: -34.74%
• 5 years: -99.18%
• 10 years: -98.57%
• Sector: Healthcare
• Industry: Biotechnology

About: Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Employees: 225